FDA Removes Boxed Warning for Combination Asthma Treatment Michele B. Kaufman, PharmD, BCGP | January 10, 2018Post-market clinical safety trials have indicated that medications containing both long-acting beta agonists (LABAs) and inhaled corticosteroids (ICSs) do not result in more serious asthma-related outcomes than treatment with ICSs alone…